Pasar al contenido principal
  • Socios aprobados
  • Acerca de ELGA
    • Acerca de ELGA
    • Empleo
    • Eventos
  • Soporte
    • Planificación de laboratorio
    • Registrar un producto
    • Register Your Product (USA & Canada Only)
  • Contacto
  • U.S.A.
  • U.K.
  • Deutschland
  • France
  • Italia
  • Brasil
  • 日本
  • 中国
Inicio ELGA LabWater
  • Productos
    • PURELAB
    • CENTRA
    • MEDICA
    • BIOPURE
    • Gama completa de productos ELGA
  • Aplicaciones
    • Análisis microbiológico
    • Bioquímica clínica
    • Cromatografía de gases
    • Cromatografía líquida
    • Electroquímica
    • Espectrofotometría
    • Espectrometría de masas
    • Espectroscopia atómica
    • Genética
    • Inmunoquímica
    • Requisitos generales de agua de laboratorio
  • Tecnologías
    • Carbón activado
    • Electrodesionización (EDI)
    • Filtración
    • Intercambio iónico
    • PureSure
    • Ultravioleta
    • Ósmosis inversa
  • Impurezas en el agua
    • Compuestos inorgánicos
    • Compuestos orgánicos
    • Gases disueltos
    • Microorganismos y bacterias
    • Partículas
  • Knowledge
    • Blog
    • Casos prácticos
    • Agua ultrapura
    • Manuales e informes técnicos
  • Productos
    • PURELAB
    • CENTRA
    • MEDICA
      • Hubgrade
      • MEDICA BIOX
    • BIOPURE
    • Gama completa de productos ELGA
      • PURELAB® Classic
  • Aplicaciones
    • Análisis microbiológico
    • Bioquímica clínica
    • Cromatografía de gases
    • Cromatografía líquida
      • Hochleistungsflüssigkeitschromatographie (HPLC)
    • Electroquímica
    • Espectrofotometría
    • Espectrometría de masas
    • Espectroscopia atómica
    • Genética
    • Inmunoquímica
    • Requisitos generales de agua de laboratorio
  • Tecnologías
    • Carbón activado
    • Electrodesionización (EDI)
    • Filtración
    • Intercambio iónico
    • PureSure
    • Ultravioleta
    • Ósmosis inversa
  • Impurezas en el agua
    • Compuestos inorgánicos
    • Compuestos orgánicos
    • Gases disueltos
    • Microorganismos y bacterias
    • Partículas
  • Knowledge
    • Blog
      • Analytical Chemistry
      • Clinical & Pharma
      • Cool Science
      • Environment and sustainability
      • Life in the lab
      • Purelab product design
      • Science of the future
      • Water Purity
      • Water in the lab
    • Casos prácticos
      • Abbott Diagnostics elige sistemas ELGA MEDICA en el sur de Asia
      • Beam Me Up, Scotty: PURELAB® Option Q Delivers Essential Ultra Pure Water
      • Argenta chooses DKSH New Zealand to deliver Ultrapure water in Animal Pharma
      • Clean Water for a Clean Future
      • LS Scientific & ELGA deliver UltraPure water to the NAFDAC Laboratory
      • Lifebrain Group chooses ELGA as water partner for new modern 24/7 PCR-COVID-19 laboratory in Vienna, Austria.
      • Critital Tests Benefit from PURELAB® Option Reliable Pure Water
      • DASA: la mayor empresa de diagnóstico médico de Brasil
      • ELGA ayuda a los laboratorios de inmunoserología a maximizar el tiempo de actividad
      • Fondazione Telethon Continues to Choose ELGA Labwater as a Trusted Partner
      • La importancia del agua ultrapura de tipo 1+ para el desarrollo de medicamentos genéricos
      • Seleccionan MEDICA® Pro para los analizadores Siemens ADVIA® del City General Hospital
      • Optimale Wasserqualität für mikrobiologische Forschung und Lehre
      • PURELAB® Option R Guarantees Pure Water for Leading Microfluidics Technology
      • PURELAB® Pulse Delivers Reliable Water Quality and Quantity for a Wide Range of Applications
      • PURELAB® flex: un sistema de formación ideal para el método de investigación actual
      • Powering Cutting-Edge Gene Research
      • Sichere Reinstwasserversorgung für präzise Produkttests
      • Zentrale Reinstwasser-Aufbereitung für Analyser
      • ELGA LabWater and Beckman Coulter Join Forces
      • Applied New Technologies Department Improves ICP, IC & HPLC Sample Turnaround Times with PURELAB®
      • Descubrir los secretos de la Antártida con ayuda del agua ultrapura
      • Advancing Genetic Technologies
      • Cross Infection Control: Pure and Simple
      • Researching effective new ways to prevent cardiovascular disease at the University of Columbia
    • Agua ultrapura
    • Manuales e informes técnicos
      • Pureza de agua de HPLC
      • HPLC en farmacia
      • Reducción del riesgo clínico
      • Sostenibilidad
  • U.S.A.
  • U.K.
  • Deutschland
  • France
  • Italia
  • Brasil
  • 日本
  • 中国
  • Política de privacidad
  • Términos y condiciones
  • Cumplimiento legal internacional
  • Patentes
  • Aviso legal
  • Inicio
  • Improving the Routine Analysis of Antipsychotic Drugs
Clinical & Pharma
Analytical Chemistry

Improving the Routine Analysis of Antipsychotic Drugs

20 Sep 2021
- by Dr Alison Halliday

Mind drugs

Researchers validate a new LC-MS/MS method for quantifying 38 antipsychotics and metabolites in plasma for therapeutic drug monitoring and forensic applications.

Antipsychotic medications have revolutionised the treatment of psychiatric disorders. These substances fall into two main classes – first-generation antipsychotics (FGAs), which were developed in the late 1950s for the treatment of psychosis symptoms. In recent decades, these have largely been replaced by second-generation antipsychotics (SGAs) – or ‘atypicals’.

The shift towards SGAs has partly been driven by the lower risk of developing severe movement problems than FGAs. However, atypicals may be more likely to cause other potentially serious side effects, including weight gain, heart problems and diabetes.

The number of patients being prescribed antipsychotics is growing worldwide, despite these safety concerns. The increasing off–label use of SGAs mainly consists of the treatment of anxiety and insomnia disorders in adults and ADHD in children.

Clinical and Forensic Analysis

The risk of undesired side effects from antipsychotics, combined with the increased use in children, drives a need for strict therapeutic drug monitoring. From a forensics perspective, more daytime traffic accidents are caused by psychotropic medication (combined with alcohol) than illicit drugs.

But many of the current methods used for clinical and forensic purposes are limited – such as analysing only a small number of antipsychotics or involving long, complex protocols.

In a new study, published in the Journal of Chromatography B, researchers develop a multi-analyte liquid chromatography triple quadrupole mass spectrometry method for the quantification of 38 antipsychotic drugs in plasma.1

A Fully Validated Method

The researchers extracted samples by a straightforward liquid-liquid extraction with methyl–tertiary–butyl–ether and the compounds of interest were chromatographically separated within six minutes. They showed that the calibration curves covered the recommended therapeutic range for all compounds, in addition to levels above and below for most substances.

After successfully validating the method according to relevant European Medicines Agency (EMA) guidelines, the team applied their new method to the analysis of samples from 137 medico-legal cases. They found 46 samples that were positive for one or more antipsychotic drugs, with their results confirming the relatively common use of the SGAs quetiapine and olanzapine, as well as the continued presence of the FGA haloperidol in Europe.

The researchers used ultrapure water produced in–house from an ELGA PURELAB® laboratory water purification system, minimising the risk of adding trace contaminants that may affect their results.

Application to Routine Analysis

In this study, researchers create a new fully validated, time-efficient quantitative multi-analyte method for therapeutic drug monitoring and forensic analysis of a wide range of antipsychotic medications in plasma.

The sample preparation and chromatographic settings were previously successfully applied in the quantification of other psychoactive drug classes (antidepressants and benzodiazepines), allowing for easy transitioning or merging of methods.

The method was further applied to more than 100 medico-legal cases and its performance was thoroughly evaluated through proficiency testing schemes.

Why Choose ELGA LabWater?

ELGA LabWater has been a trusted name in pure and ultrapure water since 1937. Our dedication to ultrapure and pure water is a guarantee that we will continue to provide the best solutions with the best service.

Reference:

  1. Degreef, M. et al. Multi–analyte LC-MS/MS quantification of 38 antipsychotics and metabolites in plasma: Method validation & application to routine analyses. J Chromatog B 2021;1179:122867 doi: https://doi.org/10.1016/j.jchromb.2021.122867

Dr Alison Halliday

After completing an undergraduate degree in Biochemistry & Genetics at Sheffield University, Alison was awarded a PhD in Human Molecular Genetics at the University of Newcastle. She carried out five years as a Senior Postdoctoral Research Fellow at UCL, investigating the genes involved in childhood obesity syndrome. Moving into science communications, she spent ten years at Cancer Research UK engaging the public about the charity’s work. She now specialises in writing about research across the life sciences, medicine and health.

HPLC Pharma

Optimise your HPLC to avoid water contamination
when manufacturing life-saving drugs.

Understand the role of HPLC and different levels of water purity in drug manufacture, analysis and pharmaceutical quality assurance

              Click Here 

 

  • Enquiry
  • Consigue una cotización
  • Reserve una demo
  • Encuentre un socio aprobado

Enquiry

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

Consigue una cotización

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

Reserve una demo

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

Call us

Can't find what you are looking for?

Support Number
+44 (0)20 3567 7300
United Kingdom Sales
+44 (0)1628 879 704
United States of America Sales
+1 877-315-3542
France Sales
+33 1 40 83 65 00
China Sales
+86 400-616-8882

 

ELGA LabWater US Head Quarters

Lane End Business Park
Lane End, High Wycombe
HP14 3BY
Reino Unido
Tel.: +44 (0) 203 567 7300
F: +44 (0) 203 567 7205

Sede central de ELGA LabWater

Lane End Business Park
Lane End, High Wycombe
HP14 3BY
Reino Unido
Tel.: +44 (0) 203 567 7300
F: +44 (0) 203 567 7205

Casos prácticos

  • Abbott Diagnostics
  • Diagnóstico médico de DASA
  • Instituto Médico NeoDIN
  • Fundación del NHS de North Staffordshire
  • Escuela técnica de Olsberg

Recursos

  • Obtenga más información sobre el agua ultrapura
  • Manuales e informes técnicos
  • Tecnologías de purificación
  • Aplicaciones
  • Impurezas en el agua

Blogs

  • Latest Blog
  • Water Purity - Different Types of Pure Water
  • What is Clinical Laboratory Reagent Water (CLSI)?
  • What is Total Organic Carbon (TOC)?
  • Idioma
    • Deutsch
    • English
    • Español
    • Français
    • Italiano
    • Português
    • 日本語
    • 中文
  • Otros sitios de Veolia
    • Veolia
    • Veolia Fondation
    • Veolia Water Technologies

© VWS (UK) Ltd. comercializado como ELGA LabWater.2022-Todos los derechos reservados.
ELGA es la marca mundial de agua de laboratorio de Veolia.

  • Política de privacidad
  • Términos y condiciones
  • Cumplimiento legal internacional
  • Patentes
  • Aviso legal
Elga Veolia
TOP

© 2017 ELGA Veolia